Clinical Trial Update: A Study Comparing Oral Calcitonin to Nasal Spray Calcitonin in Postmenopausal Osteoporotic Women [Phase 3]

View source ↗

Summary

Phase 3 trial comparing oral calcitonin to nasal spray calcitonin in postmenopausal osteoporosis completed; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Postmenopausal Osteoporosis

Drugs mentioned

• Nasal spray calcitonin (calcitonin)
• Oral calcitonin (calcitonin)

Snippet

Sponsor: Tarsa Therapeutics, Inc. | Conditions: Osteoporosis, Postmenopausal | Phase 3 | Status: COMPLETED | Results posted: 2013-11-19